WO2009001940A1 - ペリオスチンのExon-17部位によりコードされるペプチドに対する抗体を含む癌治療剤 - Google Patents
ペリオスチンのExon-17部位によりコードされるペプチドに対する抗体を含む癌治療剤 Download PDFInfo
- Publication number
- WO2009001940A1 WO2009001940A1 PCT/JP2008/061768 JP2008061768W WO2009001940A1 WO 2009001940 A1 WO2009001940 A1 WO 2009001940A1 JP 2008061768 W JP2008061768 W JP 2008061768W WO 2009001940 A1 WO2009001940 A1 WO 2009001940A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- periostin
- exon
- cancer
- antibody against
- containing antibody
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009520653A JP5238942B2 (ja) | 2007-06-27 | 2008-06-27 | ペリオスチンのExon−17部位によりコードされるペプチドに対する抗体を含む癌治療剤 |
CA2690888A CA2690888C (en) | 2007-06-27 | 2008-06-27 | Cancer therapeutic composition comprising antibody against peptide encoded by exon-17 site of periostin |
CN2008800210040A CN101888855A (zh) | 2007-06-27 | 2008-06-27 | 含有由抗骨膜素的外显子-17编码的肽的抗体的癌症治疗剂 |
EP08777680.3A EP2168599B1 (en) | 2007-06-27 | 2008-06-27 | Cancer remedy containing antibody against peptide encoded by exon-17 of periostin |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007169494 | 2007-06-27 | ||
JP2007-169494 | 2007-06-27 | ||
JP2008-033827 | 2008-02-14 | ||
JP2008033827 | 2008-02-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009001940A1 true WO2009001940A1 (ja) | 2008-12-31 |
Family
ID=40185749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/061768 WO2009001940A1 (ja) | 2007-06-27 | 2008-06-27 | ペリオスチンのExon-17部位によりコードされるペプチドに対する抗体を含む癌治療剤 |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2168599B1 (ja) |
JP (1) | JP5238942B2 (ja) |
KR (1) | KR101560843B1 (ja) |
CN (1) | CN101888855A (ja) |
CA (1) | CA2690888C (ja) |
WO (1) | WO2009001940A1 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013038696A1 (ja) | 2011-09-15 | 2013-03-21 | 国立大学法人名古屋大学 | 胸膜中皮腫患者の早期発見のための分子マーカー及びその発現解析方法 |
US9684000B2 (en) | 2010-12-16 | 2017-06-20 | Genentech, Inc. | Diagnosis and treatments relating to TH2 inhibition |
US10227396B2 (en) | 2013-03-08 | 2019-03-12 | Osaka University | Antibody against peptide encoded by Exon-21 of periostin and pharmaceutical composition for preventing or treating inflammation-associated diseases containing the same |
WO2019146621A1 (ja) * | 2018-01-25 | 2019-08-01 | 国立大学法人大阪大学 | ペリオスチンの発現量増加またはスプライシングバリアントの変化を伴う疾患の治療用医薬組成物 |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011024114A1 (en) * | 2009-08-25 | 2011-03-03 | Ecole Polytechnique Federale De Lausanne (Epfl) | Targeting extracellular matrix molecules for the treatment of cancer |
CN101773671A (zh) * | 2010-03-04 | 2010-07-14 | 北京大学第三医院 | Periostin基因的shRNA在制备抑制肿瘤的药物中的应用 |
FR2992221A1 (fr) | 2012-06-22 | 2013-12-27 | Centre Nat Rech Scient | Modification des effets immunomodulateurs des cellules |
CA2936258A1 (en) | 2014-02-07 | 2015-08-13 | Medimmune, Llc | Novel assay to detect human periostin |
KR102127478B1 (ko) * | 2019-09-06 | 2020-07-08 | 연세대학교 산학협력단 | 난소암에 대한 정보 제공 방법 및 이를 이용한 키트 |
CN117957248A (zh) * | 2021-09-13 | 2024-04-30 | 沈阳眼产业技术研究院有限公司 | 抗periostin人源化单克隆抗体及其制备方法与应用 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04502408A (ja) | 1988-12-28 | 1992-05-07 | プロテイン デザイン ラブス,インコーポレイティド | IL―2レセプターのp55 Tacタンパク質に特異的なキメラ免疫グロブリン |
JPH05268982A (ja) | 1992-03-27 | 1993-10-19 | Hoechst Japan Ltd | 骨形成作用を有する新規な蛋白質およびその製造法 |
JPH06500233A (ja) | 1990-08-29 | 1994-01-13 | ジェンファーム インターナショナル,インコーポレイティド | 異種免疫グロブリンを作る方法及びトランスジェニックマウス |
WO1994025585A1 (en) | 1993-04-26 | 1994-11-10 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
WO2002020055A1 (fr) | 2000-09-08 | 2002-03-14 | Daiichi Suntory Pharma Co., Ltd. | Médicaments contre les défaillances cardiaques |
JP2005500059A (ja) * | 2001-08-13 | 2005-01-06 | ダナ−ファーバー キャンサー インスティテュート インク. | ペリオスチンに基づく診断アッセイ法 |
WO2005019471A2 (en) | 2003-08-13 | 2005-03-03 | Temple University Of The Commonwealth System Of Higher Education | Periostin-like factor: compositions and methods for making and using the same |
WO2007077934A1 (ja) * | 2005-12-28 | 2007-07-12 | Asubio Pharma Co., Ltd. | 抗ペリオスチン抗体およびそれを含有するペリオスチンが関与する疾患の予防または治療用医薬組成物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2527571A1 (en) | 2003-05-29 | 2004-12-09 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
-
2008
- 2008-06-27 KR KR1020097026078A patent/KR101560843B1/ko active IP Right Grant
- 2008-06-27 CN CN2008800210040A patent/CN101888855A/zh active Pending
- 2008-06-27 EP EP08777680.3A patent/EP2168599B1/en active Active
- 2008-06-27 JP JP2009520653A patent/JP5238942B2/ja active Active
- 2008-06-27 CA CA2690888A patent/CA2690888C/en active Active
- 2008-06-27 WO PCT/JP2008/061768 patent/WO2009001940A1/ja active Application Filing
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04502408A (ja) | 1988-12-28 | 1992-05-07 | プロテイン デザイン ラブス,インコーポレイティド | IL―2レセプターのp55 Tacタンパク質に特異的なキメラ免疫グロブリン |
JPH06500233A (ja) | 1990-08-29 | 1994-01-13 | ジェンファーム インターナショナル,インコーポレイティド | 異種免疫グロブリンを作る方法及びトランスジェニックマウス |
JPH05268982A (ja) | 1992-03-27 | 1993-10-19 | Hoechst Japan Ltd | 骨形成作用を有する新規な蛋白質およびその製造法 |
WO1994025585A1 (en) | 1993-04-26 | 1994-11-10 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
WO2002020055A1 (fr) | 2000-09-08 | 2002-03-14 | Daiichi Suntory Pharma Co., Ltd. | Médicaments contre les défaillances cardiaques |
JP2005500059A (ja) * | 2001-08-13 | 2005-01-06 | ダナ−ファーバー キャンサー インスティテュート インク. | ペリオスチンに基づく診断アッセイ法 |
WO2005019471A2 (en) | 2003-08-13 | 2005-03-03 | Temple University Of The Commonwealth System Of Higher Education | Periostin-like factor: compositions and methods for making and using the same |
WO2007077934A1 (ja) * | 2005-12-28 | 2007-07-12 | Asubio Pharma Co., Ltd. | 抗ペリオスチン抗体およびそれを含有するペリオスチンが関与する疾患の予防または治療用医薬組成物 |
Non-Patent Citations (46)
Title |
---|
BAO S. ET AL., CANCER CELL, vol. 5, no. 4, 2004, pages 329 - 39 |
BARIL P. ET AL., ONCOGENE, vol. 26, no. 14, 2007, pages 2082 - 94 |
BEGENT ET AL., BR. J. CANCER, vol. 62, 1990, pages 487 |
CHOTHIA C. ET AL., J. MOL. BIOL., vol. 196, 1987, pages 901 - 17 |
CURR. TOP. MICROBIOL. IMMUNOL., vol. 81, 1978, pages 1 - 7 |
ERKAN M. ET AL., GASTROENTEROLOGY, vol. 132, no. 4, 2007, pages 1447 - 64 |
G. KOHLER ET AL., NATURE, vol. 256, 1975, pages 495 - 7 |
GILLAN L. ET AL., CANCER RES., vol. 62, 2002, pages 5358 - 64 |
GONZALEZ HE. ET AL., ARCH OTOLARYNGOL HEAD NECK SURG., vol. 129, 2003, pages 754 - 9 |
GREEN LL ET AL., NATURE GENETICS, vol. 7, 1994, pages 13 - 21 |
GRIGORIADIS A. ET AL., BREAST CANCER RES, vol. 8, no. 5, 2006 |
HANAHAN D. ET AL., CELL, vol. 86, 1996, pages 353 - 364 |
HORIUCHI K. ET AL., J. BONE MINER. RES., vol. 14, 1999, pages 1239 - 49 |
KABATT ET AL.: "SEQUENCES OF IMMUNOLOGICAL INTEREST", NIH PUBLICATION, NO. 91-3242 |
KATSURAGI N. ET AL., CIRCULATION, vol. 110, 2004, pages 1806 - 13 |
KIM C.-J. ET AL.: "Periostin no alternative splicing variants to Akuseika Oyobi Shijun.Ten-i tono Kanren", ANNUAL MEETING OF THE JAPAN CANCER ASSOCIATION KIJI, vol. 65TH, 2006, pages 302 + ABSTR. NO. P-572 * |
KIM CJ ET AL., INT J CANCER, vol. 117, no. 1, 2005, pages 51 - 8 |
KUDO Y. ET AL., CANCER RES, vol. 66, no. 14, 2006, pages 6928 - 35 |
LINDNER V. ET AL., ARTERIOSCLER THROMB VASE BID., vol. 25, 2005, pages 77 - 83 |
LIOTTA LA. ET AL., CELL, vol. 64, 1991, pages 327 - 336 |
LIOTTA LA. ET AL., PROC. NATL. ACAD. SCI., vol. 83, 1986, pages 3302 - 3306 |
LITVIN J. ET AL., J CELL BIOCHEM., vol. 92, 2004, pages 1044 - 61 |
MENDEZ MJ ET AL., NATURE GENETICS, vol. 15, 1997, pages 146 - 56 |
MORRISON SL. ET AL., PROC NATL ACAD SCI USA., vol. 81, 1984, pages 6851 - 5 |
NATURE, vol. 276, 1978, pages 269 |
NIKKEI, SCIENCE, 1995, pages 40 - 50 |
NILS LONBERG ET AL., NATURE, vol. 368, 1994, pages 856 - 9 |
OLKMAN J., SEMIN. CANCER BIOL, vol. 3, 1992, pages 65 - 71 |
OSHIMA A ET AL., J CELL BIOCHEM, vol. 86, no. 4, 2002, pages 792 - 804 |
PETER T ET AL., NATURE, vol. 321, 1986, pages 522 - 5 |
PETERS DG. ET AL., STROKE, vol. 32, 2001, pages 1036 - 42 |
SASAKI H. ET AL., AM J OBSTET GYNECOL., vol. 186, 2002, pages 103 - 8 |
SASAKI H. ET AL., BREAST CANCER RES TREAT., vol. 77, 2003, pages 245 - 52 |
SASAKI H. ET AL., CANCER LETT., vol. 72, no. 1, 2001, pages 37 - 42 |
SASAKI H. ET AL., CANCER, vol. 92, no. 4, 2001, pages 843 - 8 |
SCHROFF RW. ET AL., CANCER RES., vol. 45, 1985, pages 879 - 85 |
See also references of EP2168599A4 * |
SHAO R. ET AL., MOL CELL BIOL., vol. 24, 2004, pages 3992 - 4003 |
SIRIWARDENA BS. ET AL., BR J CANCER, vol. 95, no. 10, 2006, pages 1396 - 403 |
TAI I.T. ET AL.: "Periostin induction in tumor cell line explants and inhibition of in vitro cell growth by anti-periostin antibodies", CARCINOGENESIS, vol. 26, no. 5, 2005, pages 908 - 915, XP008127943 * |
TAI IT. ET AL., CARCINOGENESIS, vol. 26, 2005, pages 908 - 15 |
TAKESHITA S. ET AL., BIOCHEM J, vol. 294, 1993, pages 271 - 8 |
THIERY JP. ET AL., NAT MED., vol. 10, no. 8, 2004, pages 777 - 8 |
WANG D. ET AL., HYPERTENSION, vol. 42, 2003, pages 88 - 95 |
YAN W. ET AL., J. BIOL. CHEM., vol. 281, no. 28, 2006, pages 19700 - 8 |
YANG J ET AL., CELL, vol. 117, no. 7, 2004, pages 927 - 39 |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9684000B2 (en) | 2010-12-16 | 2017-06-20 | Genentech, Inc. | Diagnosis and treatments relating to TH2 inhibition |
US9995755B2 (en) | 2010-12-16 | 2018-06-12 | Genentech, Inc. | Diagnosis and treatments relating to TH2 inhibition |
US11226341B2 (en) | 2010-12-16 | 2022-01-18 | Genentech, Inc. | Method of treating asthma using an IL-13 antibody |
WO2013038696A1 (ja) | 2011-09-15 | 2013-03-21 | 国立大学法人名古屋大学 | 胸膜中皮腫患者の早期発見のための分子マーカー及びその発現解析方法 |
US10227396B2 (en) | 2013-03-08 | 2019-03-12 | Osaka University | Antibody against peptide encoded by Exon-21 of periostin and pharmaceutical composition for preventing or treating inflammation-associated diseases containing the same |
WO2019146621A1 (ja) * | 2018-01-25 | 2019-08-01 | 国立大学法人大阪大学 | ペリオスチンの発現量増加またはスプライシングバリアントの変化を伴う疾患の治療用医薬組成物 |
JPWO2019146621A1 (ja) * | 2018-01-25 | 2021-01-07 | 国立大学法人大阪大学 | ペリオスチンの発現量増加またはスプライシングバリアントの変化を伴う疾患の治療用医薬組成物 |
JP7261482B2 (ja) | 2018-01-25 | 2023-04-20 | 国立大学法人大阪大学 | ペリオスチンの発現量増加またはスプライシングバリアントの変化を伴う疾患の治療用医薬組成物 |
Also Published As
Publication number | Publication date |
---|---|
EP2168599A1 (en) | 2010-03-31 |
CA2690888C (en) | 2016-02-09 |
CN101888855A (zh) | 2010-11-17 |
KR101560843B1 (ko) | 2015-10-15 |
EP2168599A4 (en) | 2013-02-27 |
CA2690888A1 (en) | 2008-12-31 |
KR20100023869A (ko) | 2010-03-04 |
JP5238942B2 (ja) | 2013-07-17 |
JPWO2009001940A1 (ja) | 2010-08-26 |
EP2168599B1 (en) | 2016-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009001940A1 (ja) | ペリオスチンのExon-17部位によりコードされるペプチドに対する抗体を含む癌治療剤 | |
WO2009040420A3 (en) | Use of a monoterpene to increase tissue repair | |
WO2007089454A3 (en) | Methods for enhancing skin treatments | |
WO2010062581A3 (en) | A botanical composition for enhanced skin repair and uses thereof | |
WO2009158128A3 (en) | Dressing assemblies for wound treatment using reduced pressure | |
WO2008036238A3 (en) | Use of lxr modulators for the prevention and treatment of skin aging | |
WO2009075882A3 (en) | Impaired wound healing compositions and treatments | |
WO2010065435A3 (en) | System and method for mechanical closure of wounds | |
WO2010054167A3 (en) | Limited proteolysis of cd2ap and progression of renal disease | |
WO2008143954A3 (en) | Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto | |
WO2009067605A3 (en) | Preparations, methods and kits useful for treatment of cough | |
EA200901555A1 (ru) | Композиция местного применения по уходу за кожей и способ лечения | |
WO2010030728A3 (en) | Devices and systems for delivery of therapeutic agents to body lumens | |
EP2500044A3 (en) | Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent | |
WO2008012555A3 (en) | Epitope reduction therapy | |
WO2007117580A3 (en) | Apparatus and method for skin treatment with compression and decompression | |
WO2007081879A3 (en) | Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis | |
WO2006105450A3 (en) | Compositions and methods for treating acne | |
WO2009154840A3 (en) | Compositions and methods using stem cells in cutaneous wound healing | |
WO2006005455A3 (en) | Amino, amino acid or peptide conjugates of retinoic acid | |
WO2008033804A3 (en) | Quantum dot barcode structures and uses thereof | |
WO2010132370A3 (en) | Soluble tlt-1 for the treatment and diagnosis of sepsis | |
WO2007135546A3 (en) | TREATMENT OF CANCER WITH ANTI-IL-1α ANTIBODIES | |
WO2010054377A3 (en) | Fully human antibodies against n-cadherin | |
WO2007120485A3 (en) | Methods of treating pain with alkylxanthines and antiepileptics and compositions for use therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200880021004.0 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08777680 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2009520653 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2690888 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 20097026078 Country of ref document: KR Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2008777680 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008777680 Country of ref document: EP |